Possible extracardiac predictors of aortic dissection in Marfan syndrome

Bence Agg, Kálmán Benke1, Bálint Szilveszter

  • 1Heart and Vascular Center, Semmelweis University, Városmajor str, 68, 1122 Budapest, Hungary. kalman.benke@gmail.com.

Abstract

Insights

Predicting aortic dissection in Marfan syndrome (MFS) is crucial. Easily measurable factors like TGF-β serum levels, MMP-3, and striae atrophicae may help identify high-risk MFS patients for timely aortic root replacement.

Area of Science:

  • Cardiovascular Research
  • Genetics and Genomics
  • Biomarker Discovery

Background:

  • Aortic diameter alone is insufficient for predicting aortic dissection in Marfan syndrome (MFS).
  • Optimal timing for preventive aortic root replacement (ARR) in MFS is challenging.
  • Family history and aortic growth rate are not decisive predictors for MFS complications.

Purpose of the Study:

  • To identify novel predictors of aortic dissection in Marfan syndrome.
  • To investigate the role of TGF-β serum levels and MMP expression in MFS aortic dissection.
  • To explore clinical parameters for risk stratification in MFS patients.

Main Methods:

  • Established a Marfan Biobank with 79 MFS patients.
  • Analyzed 39 MFS patients who underwent ARR, categorized by surgical indication.
  • Measured TGF-β serum levels (ELISA) and MMP-3/MMP-9 expression (RT-PCR); assessed clinical parameters.

Main Results:

  • Elevated TGF-β serum levels (p < 0.0001) and increased MMP-3 expression (p = 0.062) in patients with aortic dissection compared to the annuloaortic ectasia group.
  • Striae atrophicae were significantly more common in the dissection group (92% vs. 41%, p = 0.027).
  • TGF-β serum level, MMP-3, and striae atrophicae emerged as potential predictors.

Conclusions:

  • Striae atrophicae, TGF-β serum level, and MMP-3 are easily measurable parameters that may predict aortic dissection risk in MFS.
  • Proposed a new classification of MFS as benign or malignant based on these predictors.
  • Findings could aid in determining the optimal timing for prophylactic ARR in MFS patients.

Related Concept Videos

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
650
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K